Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial Jeroudi O, Abdel-Karim A-R, Michael T, Lichtenwalter C, de Lemos J, Obel O, Addo T, Roesle M, Haagen D, Rangan B, Raghunathan D, DaSilva M, Saeed B, Bissett J, Sachdeva R, Voudris V, Kariofillis P, Kar B, Roosen J, Fasseas P, Berger P, Banerjee S, Brilakis E December 30, 2011 | 10.4244/EIJV7I8A150
New issue Discover the Special Edition on valvular heart disease prepared for PCR London Valves (3D-TEE model - Optimal implantation) November 15, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial Medical device regulation in Europe – what is changing and how can I become more involved? October 18, 2019
